Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
332,525,463
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
82,070,744
-
Shares change
-
+1,882,256
-
Total reported value, excl. options
-
$116,553,437
-
Value change
-
+$2,653,090
-
Put/Call ratio
-
196%
-
Number of buys
-
68
-
Number of sells
-
-45
-
Price
-
$1.42
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q2 2025
169 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q2 2025.
PRECIGEN, INC. - Common Stock (PGEN) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82,070,744 shares
of 332,525,463 outstanding shares and own 25% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (16,268,741 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (11,276,000 shares), BlackRock, Inc. (11,145,501 shares), VANGUARD GROUP INC (9,070,029 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (4,278,662 shares), GEODE CAPITAL MANAGEMENT, LLC (3,749,182 shares), STATE STREET CORP (3,029,100 shares), MORGAN STANLEY (2,040,974 shares), Parkman Healthcare Partners LLC (1,542,823 shares), and Schonfeld Strategic Advisors LLC (1,438,463 shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.